Amrize (NYSE:AMRZ) Research Coverage Started at Longbow Research

Longbow Research began coverage on shares of Amrize (NYSE:AMRZ) in a research note released on Monday, MarketBeat Ratings reports. The firm issued a buy rating on the stock.

Several other equities analysts have also commented on the stock. Oppenheimer lowered their price objective on shares of Amrize from $62.00 to $55.00 and set an “outperform” rating for the company in a research report on Friday, September 18th. Truist Financial reduced their target price on shares of Amrize from $48.00 to $35.00 and set a “hold” rating on the stock in a report on Monday, October 5th. Royal Bank Of Canada reduced their target price on shares of Amrize from $48.00 to $32.00 and set an “underperform” rating on the stock in a report on Friday, October 9th. UBS Group decreased their target price on shares of Amrize from $57.00 to $42.00 and set a “neutral” rating on the stock in a research report on Tuesday, September 22nd. Finally, DA Davidson set a $40.00 price target on shares of Amrize in a report on Friday, October 9th. One research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have given a Hold rating and four have given a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $50.00.

Amrize Stock Down 0.3%

Shares of AMRZ opened at $36.30 on Monday. The stock has a market capitalization of $20.07 billion, a price-to-earnings ratio of 16.73, a price-to-earnings-growth ratio of 1.28 and a beta of 0.20. Amrize has a 1 year low of $35.78 and a 1 year high of $65.94. The business’s 50 day simple moving average is $41.40 and its 200-day simple moving average is $49.03. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.10 and a quick ratio of 0.73.

Amrize (NYSE:AMRZ) last posted its earnings results on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing analysts’ consensus estimates of $0.92 by ($0.04). Amrize had a net margin of 9.89% and a return on equity of 10.22%. The business had revenue of $3.49 billion during the quarter. As a group, equities analysts expect that Amrize will post 2.46 earnings per share for the current fiscal year.

Amrize Dividend Announcement

The business also recently announced a dividend, which was paid on Wednesday, August 26th. Stockholders of record on Tuesday, August 18th were given a dividend of $0.11 per share. The ex-dividend date of this dividend was Tuesday, August 18th. Amrize’s payout ratio is currently 5.07%.

Insider Activity

In related news, insider Stephen Clark purchased 5,260 shares of the firm’s stock in a transaction that occurred on Tuesday, August 11th. The shares were bought at an average price of $47.31 per share, for a total transaction of $248,850.60. Following the acquisition, the insider owned 10,637 shares of the company’s stock, valued at approximately $503,236.47. This represents a 97.82% increase in their position. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CFO Baris Oran purchased 3,000 shares of the stock in a transaction that occurred on Tuesday, August 11th. The stock was bought at an average price of $47.38 per share, with a total value of $142,140.00. Following the completion of the transaction, the chief financial officer owned 3,000 shares of the company’s stock, valued at $142,140. The trade was a ∞ increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last quarter, insiders have purchased 48,983 shares of company stock worth $2,158,755. Company insiders own 0.54% of the company’s stock.

Institutional Investors Weigh In On Amrize

Hedge funds and other institutional investors have recently made changes to their positions in the company. Pictet Asset Management Holding SA boosted its position in Amrize by 4.7% in the 1st quarter. Pictet Asset Management Holding SA now owns 5,216,765 shares of the company’s stock valued at $283,017,000 after buying an additional 234,731 shares during the period. Allspring Global Investments Holdings LLC grew its stake in Amrize by 3.7% in the 1st quarter. Allspring Global Investments Holdings LLC now owns 4,772,941 shares of the company’s stock worth $263,371,000 after acquiring an additional 171,622 shares in the last quarter. Barclays PLC increased its position in shares of Amrize by 95.4% during the fourth quarter. Barclays PLC now owns 4,614,593 shares of the company’s stock worth $249,557,000 after acquiring an additional 2,253,431 shares during the period. First Manhattan CO. LLC. increased its position in shares of Amrize by 20.0% during the fourth quarter. First Manhattan CO. LLC. now owns 4,036,704 shares of the company’s stock worth $218,305,000 after acquiring an additional 672,030 shares during the period. Finally, River Road Asset Management LLC increased its position in shares of Amrize by 26.1% during the fourth quarter. River Road Asset Management LLC now owns 2,883,536 shares of the company’s stock worth $155,942,000 after acquiring an additional 597,542 shares during the period.

Amrize Company Profile

Amrize Ltd. is a North American building solutions company that produces and supplies essential construction materials and related products. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, concrete products and roofing systems used in residential, commercial and infrastructure projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and other operating sites. Its products support a range of construction applications, including roads, bridges, buildings, homes and other major infrastructure.

Amrize was established as the result of the separation of Holcim’s North American business and began operating as an independent, publicly traded company in 2025.